Suppression of the proliferation of cancer cell lines, KB-3-1 and K562 cells preceded by a decrease in intracellular pH caused by phenoxazine derivatives

Oncology Reports

Volumn 19, Issue 5, 2008, Pages 1253-1258

  Che, Xiao Fang ^a   Akiyama, Shin Ichi ^a   Tomoda, Akio ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Intracellutar pH; K562 cells; KB 3 1 cells; Phenoxazines; Proliferation

Indexed keywords

2 AMINO 4,4 ALPHA DIHYDRO 4 ALPHA,7 DIMETHYL 3H PHENOXAZINE 3 ONE; 2 AMINOPHENOXAZINE 3 ONE; PHENOXAZINE DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DNA; OXAZINE DERIVATIVE; PHENOXAZINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PH; CELL PROLIFERATION; CELL STRAIN K 562; CELL STRAIN KB; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; INHIBITION KINETICS; PRIORITY JOURNAL; CHEMICAL MODEL; CHEMISTRY; DOSE RESPONSE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; PH; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN-ION CONCENTRATION; K562 CELLS; MODELS, CHEMICAL; OXAZINES; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 47549104507     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.5.1253     Document Type: Article

References (27)

1. Lagadic-Gossmann D, Huc L and Lecureur V: Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ 11: 953-961, 2004.
2. Shrode LD, Tapper H and Grinstein S: Role of intracellular pH in proliferation, transformation and apoptosis. J Bioenerg Biomembr 29: 393-399, 1997.
3. + exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol 42: 527-552, 2002.
4. Matsuyama S, Liopis J, Deveraux QL, Tsien RY and Reed JC: Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol 2: 319-325, 2000.
5. Matsuyama S and Reed JC: Mitochondria-dependent apoptosis and cellular pH regulation. Cell Death Differ 7: 1155-1165, 2000.
6. 2+ and pH. Biochem Biophys Res Commun 186: 782-789, 1992.
7. Perez-Sala D, Collado-Escobar D and Mollinedo F: Intracellular alkalinization suppresses lovastain-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease. J Biol Chem 270: 6235-6245, 1995.
8. Litman T, Pedersen SF, Karamhoft B, Skovsgaard T and Hoffmann EK: pH regulation in sensitive multidrug resistant Eharlich ascites tumor cells. Cell Physiol Biochem 8: 137-150, 1998.
9. Gottlieb RA, Nordberg J, Skowronski E and Babior BM: Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc Natl Acad Sci USA 93: 654-658, 1996.
10. Goossens J-F, Henichrt J-P, Dassonneville L, Facompre M and Bailly C: Relation between intracellular acidification and camptothecin-induced apoptosis in leukemia cells. Eur J Pharm Sci 10: 125-131, 2000.
11. Barry MA, Reynolds JE and Eastman A: Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res 53: 2349-2357, 1993.
12. Shimamoto T, Tomoda A, Ishida R and Ohyashiki K: Antitumor effects of a novel phenoxazine derivative on human leukemia cell lines in vitro and in vivo. Clin Cancer Res 7: 704-708, 2001.
13. Kato S, Shirato K, Imaizumi K, Toyota H, Mizuguchi J, Odawara, Che XF, Akiyama S, Abe A and Tomoda A: Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2. Oncol Rep 15: 843-848, 2006.
14. Shirato K, Imaizumi K, Abe A and Tomoda A: Effects of phenoxazines, 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one and 2-amino-phenoxazine-3-one on cellular proliferation and apoptosis in human neuroblastoma cell line NB-1 cells. Biol Pharm Bull 30: 331-336, 2007.
15. Kasuga T, Tabuchi T, Shirato K, Imaizumi K and Tomoda A: Caspase-independent cell death revealed in human gastric cancer cell lines, KATO III and MKN45 treated with phenoxazine derivatives. Oncol Rep 17: 409-415, 2007.
16. Azuine MA, Tokuda H, Takayasu J, Enjyo F, Mukainaka T, Konoshima T, Nishino H and Kapadia GJ: Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models. Pharmacol Res 49: 161-169, 2004.
17. Enoki E, Sada K, Qu X, Kyo S, Shahjahan Miah SM, Hatani T, Tomoda A and Yamamura H: The phenoxazine derivative Phx-1 suppresses IgE-mediated degranulation in rat basophilic leukemia RBL-2H3 cells. J Pharmacol Sci 94: 329-333, 2004.
18. Hara K, Okamoto M, Aki T, Yagita H, Tanaka H. Mizukami Y, Nakamura, H, Tomoda A, Hamasaki N and Kang D: Synergistic enhancement of TRAIL- and tumor necrosis factor α-induced cell death by a phenoxazine derivative. Mol Cancer Ther 4: 1121-11279, 2005.
19. 10-substituted phenoxazines as potent and specific inhibitors of Akt signaling. J Biol Chem 280: 31924-319359, 2005.
20. Tomoda A, Arai S. Ishida R, Shimamoto T and Ohyashiki K: An improved method for the rapid preparation of 2-amino-4,4α-dihydro-4α, 7-dimethyl-3H-phenoxazine-3-one, a novel antitumor agent. Bioorg Med Chem Lett 11: 1057-1058, 2001.
21. Shimizu S, Suzuki M, Tomoda A, Arai S, Taguchi H, Hanawa T and Kamiya S: Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria. Tohoku J Exp Med 203: 47-52, 2004.
22. Gillies RJ: Intracellular pH and growth control in eukaryotic cells. In: The Transformed Cell. Cameron IL (ed). Academic Press, New York, pp348-382, 1981.
23. Warburg O: On the origin of cancer cells. Science 24: 309-314, 1956.
24. Tomoda A, Tsuda-Hirota S and Minakami S: Glycolysis of red cells suspended in solutions of impermeable solutes. Biochemistry 81: 697-701, 1977.
25. Wenner C: Regulation of energy metabolism in normal and tumor tissues. In: Cancer: A Comprehensive Treatise. Becker FF (eds). Vol. 3, Plenum, New York, pp389-403, 1975.
26. Hendrich AB, Stanczak K, Komorowska M, Motohashi N, Kawase M and Michalak K: A study on the perturbation of model lipid membranes by phenoxazines. Bioorg Med Chem 14: 5948-5954, 2006.
27. Kim KM and Lee UJ: Amiloride augments TRAIL-induced apoptosis death by inhibiting phosphorylation of kinases and phosphatases associated with the P13K-Akt pathway. Oncogene 24: 355-366, 2005.